When Common Antibiotics Fail: The Growing Threat of Resistant UTIs
A New Dawn Against Superbugs: Personalized Phage Therapy Conquers Drug-Resistant Infections
MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs